AstraZeneca PLC (AZN) Income Annual - Discounting Cash Flows
AZN
AstraZeneca PLC
AZN (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
2003
12-31
2002
12-31
2001
12-31
2000
12-31
1999
12-31
1998
12-31
1997
12-31
1996
12-31
1995
12-31
1994
12-31
1993
12-31
1992
12-31
1991
12-31
1990
12-31
Report Filing 2025-11-06 2025-02-18 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31 2003-12-31 2002-12-31 2001-12-31 2000-12-31 1999-12-31 1998-12-31 1997-12-31 1996-12-31 1995-12-31 1994-12-31 1993-12-31 1992-12-31 1991-12-31 1990-12-31
Revenue 58,127 54,073 45,811 44,351 37,417 26,617 24,384 22,090 22,465 23,002 24,708 26,547 25,806 27,973 33,591 33,269 32,804 31,601 29,559 26,475 23,950 21,426 18,849 17,841 16,480 18,116 15,134 11,318 8,586 9,184 7,568 7,004 6,568 6,035 7,352 7,349
Cost of Revenue 10,301 10,207 8,268 12,391 12,437 5,299 4,921 4,936 4,318 4,126 4,646 5,842 5,261 5,393 6,026 6,389 5,775 6,598 6,419 5,559 5,356 5,193 4,463 4,520 4,456 0 3,248 2,031 0 0 0 0 0 0 0 0
Gross Profit 47,826 43,866 37,543 31,960 24,980 21,318 19,463 17,154 18,147 18,876 20,062 20,705 20,545 22,580 27,565 26,880 27,029 25,003 23,140 20,916 18,594 16,233 14,386 13,321 12,024 18,116 11,886 9,287 0 0 0 0 0 0 0 0
Operating Expenses 35,025 33,863 29,350 28,203 23,924 16,156 16,539 13,767 14,470 13,974 15,948 18,568 16,833 14,432 14,770 15,386 15,486 15,859 15,046 12,700 12,092 11,686 10,379 9,315 7,868 14,451 8,456 6,860 -1,790 -1,786 -1,281 -1,030 -1,041 -429.2 -1,276 -1,157
Research & Development 15,047 13,583 10,935 9,762 9,736 5,991 6,059 5,932 5,757 5,890 5,997 5,579 4,821 5,243 5,523 5,318 4,409 5,179 5,162 3,902 3,379 3,467 3,012 3,069 2,687 2,895 2,472 2,103 1,079 1,031 848.3 809.8 767.7 676.4 703.6 704.1
Selling, General and Administrative 20,307 20,224 18,222 17,984 15,590 11,896 11,985 10,982 10,543 9,739 11,516 13,324 12,512 10,159 11,507 10,780 11,630 11,204 10,612 9,322 8,906 8,445 7,555 6,139 5,549 0 4,915 3,936 0 0 0 0 0 0 0 0
Other Operating Expenses -329 56 193 457 -1,402 -1,731 -1,505 -3,147 -1,830 -1,655 -1,565 -335 -500 -970 -2,260 -712 -553 -524 -728 -524 -193 -226 -188 107 -368 11,556 1,069 821 -2,870 -2,817 -2,129 -1,840 -1,809 -1,106 -1,980 -1,861
Operating Income 12,801 10,003 8,193 3,757 1,056 5,162 2,924 3,387 3,677 4,902 4,114 2,137 3,712 8,148 12,795 11,494 11,543 9,144 8,094 8,216 6,502 4,547 4,007 4,006 4,156 3,665 3,430 2,427 1,790 1,786 1,281 1,030 1,041 429.2 1,276 1,157
Net Non-Operating Interest -1,350 -1,337 -1,288 -1,249 -1,233 -1,189 -1,237 -1,228 -1,251 -1,308 -1,003 -930 -460 -477 -508 -980 -591 -463 0 0 0 0 0 0 149.3 137.4 -2 -69.72 -24.8 -37.68 -55.63 -89.11 -152.4 -241.2 -338.7 -349.1
Interest Income 216 345 301 81 43 83 165 138 109 59 36 33 32 42 46 42 462 854 0 0 0 0 0 0 284.1 268.8 164.9 36.52 76.04 71.93 40.18 28.14 50.29 42.47 54.26 40.51
Interest Expense 1,566 1,682 1,589 1,330 1,276 1,272 1,402 1,366 1,360 1,367 1,039 963 492 519 554 1,022 1,053 1,317 0 0 0 0 0 0 134.8 131.4 166.9 106.2 100.8 109.6 95.8 117.3 202.7 283.6 392.9 389.6
Equity & Other Income/(Expense) -12 25 -6 -7 -88 -57 -139 -166 -199 -42 -42 39 15 -25 -4 463 -145 0 -111 327 165 297 70 357 -47.32 47.8 128 766.7 21.49 -78.78 -268.9 89.11 47.33 -33.37 56.14 -125.4
Income Before Tax 11,439 8,691 6,899 2,501 -265 3,916 1,548 1,993 2,227 3,552 3,069 1,246 3,267 7,646 12,283 10,977 10,807 8,681 7,983 8,543 6,667 4,844 4,077 4,363 4,258 3,851 3,556 3,124 1,787 1,670 956.5 1,030 936.3 154.7 993.6 682.8
Income Tax Expense 2,035 1,650 938 -792 -380 772 321 -57 -641 146 243 11 696 1,376 2,333 2,896 3,263 2,551 2,356 2,480 1,943 1,161 1,033 1,177 1,153 1,299 1,048 903 570.3 548 414.1 328.3 279.6 15.17 312.5 231.5
Income Attributable to Non-Controlling Interest 5 6 6 5 3 -52 -108 -105 -133 -93 1 2 15 30 33 28 23 29 32 20 18 19 8 348.6 -1,051 10.46 1,366 1,036 9.92 20.55 23.18 9.38 19.23 18.2 35.55 23.15
Net Income 9,399 7,035 5,955 3,288 112 3,196 1,335 2,155 3,001 3,499 2,825 1,233 2,556 6,240 9,917 8,053 7,521 6,101 5,595 6,043 4,706 3,664 3,036 2,837 4,156 2,541 1,142 1,185 1,207 1,101 519.2 692.6 637.5 121.3 645.6 428.2
Depreciation and Amortization 4,936 5,065 4,934 5,254 4,102 2,896 3,762 3,753 3,036 2,357 2,852 3,282 4,583 2,518 2,550 2,741 2,087 2,620 1,856 1,345 1,327 1,268 1,293 960 860 929 1,069 821 357.1 371.6 299.8 276.7 254.4 242.7 291.9 300.9
EBITDA 17,737 15,068 13,127 9,011 5,158 8,058 6,686 7,140 6,713 7,259 6,966 5,419 8,295 10,666 15,345 14,235 13,630 11,764 9,950 9,561 7,829 5,815 5,300 4,966 5,016 4,594 4,499 3,248 2,147 2,158 1,581 1,307 1,296 671.9 1,568 1,458
Earnings Per Share (EPS) 3.04 1.14 1.91 1.06 0.04 1.22 0.52 0.85 1.19 1.39 1.12 0.49 1.02 2.5 3.67 2.8 2.6 2.1 1.87 1.93 1.46 109 89 0.82 0.83 0.72 0.32 0.74 0.64 0.58 0.28 0.37 0.38 0.085 0.45 0.3
Diluted Earnings Per Share 3.02 1.13 1.91 1.06 0.04 1.22 0.52 0.85 1.19 1.38 1.12 0.49 1.02 2.47 3.65 2.79 2.6 2.1 1.87 1.93 1.46 109 89 0.82 0.83 0.72 0.32 0.73 0.64 0.58 0.28 0.37 0.38 0.085 0.45 0.3
Weighted Average Shares Outstanding 3,127 3,100 3,124 3,096 2,836 2,624 2,602 2,534 2,532 2,530 2,528 2,524 2,504 2,522 2,722 2,876 2,896 2,906 2,990 3,128 3,234 3,346 3,418 3,466 3,516 3,536 3,552 1,867 1,896 1,894 1,892 1,892 1,700 1,433 1,433 1,433
Diluted Weighted Average Shares Outstanding 3,122 3,126 3,124 3,120 2,854 2,626 2,602 2,534 2,534 2,532 2,530 2,528 2,508 2,528 2,734 2,892 2,900 2,906 2,996 3,140 3,236 3,346 3,418 3,470 3,516 3,536 3,552 1,867 1,902 1,894 1,892 1,892 1,700 1,433 1,433 1,433
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program